{"protocolSection":{"identificationModule":{"nctId":"NCT03062397","orgStudyIdInfo":{"id":"JPI-289-P2"},"organization":{"fullName":"Jeil Pharmaceutical Co., Ltd.","class":"INDUSTRY"},"briefTitle":"Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke","officialTitle":"A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2019-11","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-12-09","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2021-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2017-02-20","studyFirstSubmitQcDate":"2017-02-20","studyFirstPostDateStruct":{"date":"2017-02-23","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-11-14","lastUpdatePostDateStruct":{"date":"2019-11-18","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Jeil Pharmaceutical Co., Ltd.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke"},"conditionsModule":{"conditions":["Acute Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"SEQUENTIAL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":110,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Low-dose group","type":"EXPERIMENTAL","description":"JPI-289 Low dose or placebo","interventionNames":["Drug: JPI-289 Low-dose"]},{"label":"High-dose group","type":"EXPERIMENTAL","description":"JPI-289 High dose or placebo","interventionNames":["Drug: JPI-289 High-dose"]},{"label":"Placebo group","type":"PLACEBO_COMPARATOR","description":"Same dosage of JPI-289 low and high dose","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"JPI-289 Low-dose","description":"JPI-289 Low dose will be intravenously administered during 24 hours","armGroupLabels":["Low-dose group"]},{"type":"DRUG","name":"JPI-289 High-dose","description":"JPI-289 High dose will be intravenously administered during 24 hours","armGroupLabels":["High-dose group"]},{"type":"DRUG","name":"Placebo","description":"Same dosage of JPI-289 Low and Hogh dose will be intravenously administered during 24 hours","armGroupLabels":["Placebo group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Infact growth ratio from baseline","timeFrame":"4 days from baseline"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects with acute ischemic stroke, aging â‰¥ 19\n* Confirmed to have acute anterior circulation cerebral artery occlusion in intracranial internal carotid artery (IICA) or middle cerebral artery (MCA) M1 segment by CT or MR angiography.\n* National Institutes of Health Stroke Scale(NIHSS) is 6\\~30 before endovascular recanalization therapy (ERT)\n* Subject who is reperfused with 2b or 3 stages of thrombolysis in cerebral infarction (TICI) (However, if angiography is conducted for thrombectomy after IV tPA treatment and the effect of tPA results in TICI 2b-3 reperfusion, the subject can participate)\n* Subject who can administer IP within 6.5 hrs of symptom development\n* Subject who can administer IP within 30 min of vascular reperfusion\n* Subject who can evaluate MRI within 90 min of vascular reperfusion\n\nExclusion Criteria:\n\n* Subject who is contraindicated for endovascular recanalization\n* Subject who has hypersensitivity to contrast agent or component of investigational product\n* Prohibited or unable to perform MRI test\n* Medical history that is related to bleeding\n* History of hemorrhagic stroke within 6 months of study participation\n* Subjects with chronic liver disorder\n* Kidney disorder (Serum creatinine \\> 3 mg/dL)\n* Life expectancy is less than 3 months due to concomitant disease other than stroke\n* Pregnant or lactating women\n* Those who have taken tirofiban (anticoagulant agent) during endovascular recanalization therapy\n* Those who have taken other investigational drugs and/or medical instruments 12 weeks prior to screening\n* Subject is unable to be followed up\n* Subject is deemed unable to participate the study in the opinion of the investigator.","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Byung Woo Yoon, MD., PhD","role":"CONTACT","email":"bwyoon@snu.ac.kr"},{"name":"Yong Woo Lee, MSC","role":"CONTACT","email":"ywlee97@jeilpharm.co.kr"}],"locations":[{"facility":"Dong-A University Hospital","status":"RECRUITING","city":"Busan","country":"Korea, Republic of","contacts":[{"name":"Jae Kwan Cha, MD., PhD","role":"CONTACT","email":"nrcjk65@gmail.com"}],"geoPoint":{"lat":35.10278,"lon":129.04028}},{"facility":"Inje University Busan Paik Hospital","status":"RECRUITING","city":"Busan","country":"Korea, Republic of","contacts":[{"name":"Eung-Gyu Kim, MD., PhD","role":"CONTACT"}],"geoPoint":{"lat":35.10278,"lon":129.04028}},{"facility":"Gyeongsang National University Changwon Hospital","status":"RECRUITING","city":"Changwon","country":"Korea, Republic of","contacts":[{"name":"Seunguk Jung, MD","role":"CONTACT"}],"geoPoint":{"lat":35.22806,"lon":128.68111}},{"facility":"Yeungnam University Medical Center","status":"RECRUITING","city":"Daegu","country":"Korea, Republic of","contacts":[{"name":"Jun Lee, MD., PhD","role":"CONTACT","email":"junlee@ynu.ac.kr"}],"geoPoint":{"lat":35.87028,"lon":128.59111}},{"facility":"Chonnam National University Hospital","status":"RECRUITING","city":"Gwangju","country":"Korea, Republic of","contacts":[{"name":"Man Seok Park, MD., PhD","role":"CONTACT","email":"mspark@chonnam.ac.kr"}],"geoPoint":{"lat":35.15472,"lon":126.91556}},{"facility":"Inje University Ilsan Paik Hospital","status":"RECRUITING","city":"Gyeonggi-do","country":"Korea, Republic of","contacts":[{"name":"Keun Sik Hong, MD., PhD","role":"CONTACT","email":"nrhks@paik.ac.kr"}],"geoPoint":{"lat":37.58944,"lon":126.76917}},{"facility":"Seoul National University Bundang Hospital","status":"RECRUITING","city":"Gyeonggi-do","country":"Korea, Republic of","contacts":[{"name":"Moon Ku Han, MD., PhD","role":"CONTACT","email":"mkhan@snu.ac.kr"}],"geoPoint":{"lat":37.58944,"lon":126.76917}},{"facility":"Catholic Kwandong University International St. Mary'S Hospital","status":"RECRUITING","city":"Incheon","country":"Korea, Republic of","contacts":[{"name":"Sang Joon An, MD","role":"CONTACT"}],"geoPoint":{"lat":37.45646,"lon":126.70515}},{"facility":"Jeju National University Hospital","status":"RECRUITING","city":"Jeju","country":"Korea, Republic of","contacts":[{"name":"Jay Chol Choi, M.D., PhD","role":"CONTACT","email":"jaychoi@jejunu.ac.kr"}],"geoPoint":{"lat":33.50972,"lon":126.52194}},{"facility":"Gyeongsang National University Hospital","status":"RECRUITING","city":"Jinju","country":"Korea, Republic of","contacts":[{"name":"Chang Heon Kim, MD.,PhD","role":"CONTACT","email":"honey0407@naver.com"}],"geoPoint":{"lat":35.19278,"lon":128.08472}},{"facility":"Pusan National University Hospital","status":"RECRUITING","city":"Pusan","country":"Korea, Republic of","contacts":[{"name":"Sang Min Sung, MD. PhD","role":"CONTACT","email":"aminoff@hanmail.net"}],"geoPoint":{"lat":35.10278,"lon":129.04028}},{"facility":"Ewha Womans University Seoul Hospital","status":"RECRUITING","city":"Seoul","country":"Korea, Republic of","contacts":[{"name":"Tae Jin Song, MD., PhD","role":"CONTACT"}],"geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Hanyang University Hospital","status":"RECRUITING","city":"Seoul","country":"Korea, Republic of","contacts":[{"name":"Young Seo Kim, MD. PhD","role":"CONTACT","email":"aescula@daum.net"}],"geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Korea University Guro Hospital","status":"RECRUITING","city":"Seoul","country":"Korea, Republic of","contacts":[{"name":"Kyung Mi Oh, MD., PhD","role":"CONTACT","email":"okyungmi@korea.ac.kr"}],"geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Seoul National University Hospital","status":"RECRUITING","city":"Seoul","country":"Korea, Republic of","contacts":[{"name":"Byung Woo Yoon, MD., PhD","role":"CONTACT","email":"bwyoon@snu.ac.kr"}],"geoPoint":{"lat":37.566,"lon":126.9784}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}